# Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-versus-tocilizumab-in-anti-tnf-inadequate-responder-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Frances Humby,Patrick Durez,Maya H Buch,Myles Lewis,Hasan Rizvi,Felice Rivellese,Alessandra Nerviani,Giovanni Giorli,Arti Mahto,Carlomaurizio Montecucco,Bernard Lauwerys,Nora Ng,Pauline Ho,Michele Bombardieri,Vasco C. Romão,Patrick Verschueren,Stephen Kelly,Pier Paolo Sainaghi,Nagui Gendi,Bhaskar Dasgupta,Alberto Cauli,Piero Reynolds,Juan D. Cañete,Robert J. Moots,Peter C. Taylor,Christopher J Edwards,John D. Isaacs,Peter Sasieni,Ernest Choy,Costantino Pitzalis,Charlotte Thompson,Serena Bugatti,Mattia Bellan,Mattia Congia,Christopher Holroyd,Arthur G. Pratt,João Eurico Fonseca,Laura White,Louise Warren,Joanna Peel,Rebecca Hands,Liliane Fossati‐Jimack,Gaye Hadfield,Georgina Thorborn,Julio Ramírez,Raquel Celis |
| Citations | 322 |
| DOI | 10.1016/s0140-6736(20)32341-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thelancet.com/article/S0140673620323412/pdf |
| OpenAlex ID | https://openalex.org/W3121929194 |
| PMID | 33485455 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Christopher J Edwards](https://scholariq.org/researchers/christopher-j-edwards/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.